Vid Desai FDA’s Chief Information Officer | Official Website
Vid Desai FDA’s Chief Information Officer | Official Website
This is a 40% decrease from the number of companies inspected in the previous quarter, when 15 companies received 15 inspections.
Most of the companies inspected at the time were involved in the Biologics sector. The second most common type of company inspected worked in the Food and Cosmetics sector.
There were five companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. Four should take voluntary action to correct their management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| American Infertility of New York, P.C. | Biologics | 05/01/2024 | Voluntary Action Indicated (VAI) |
| BonBon NYC, LLC. | Food and Cosmetics | 05/07/2024 | No Action Indicated (NAI) |
| California Cryobank, LLC | Biologics | 06/07/2024 | Voluntary Action Indicated (VAI) |
| Extend Fertility, LLC | Biologics | 04/19/2024 | Voluntary Action Indicated (VAI) |
| Foodmatch, Inc. | Food and Cosmetics | 05/06/2024 | No Action Indicated (NAI) |
| Kindbody Bryant Park | Biologics | 05/28/2024 | No Action Indicated (NAI) |
| Lenox Hill Hospital | Biologics | 04/01/2024 | Voluntary Action Indicated (VAI) |
| Manhattan Reproductive Medicine, PC | Biologics | 05/24/2024 | No Action Indicated (NAI) |
| New York University Langone Fertility Center | Biologics | 04/17/2024 | No Action Indicated (NAI) |
Alerts Sign-up